Literature DB >> 23881353

Measurement of pneumococcal polysaccharide vaccine responses for immunodeficiency diagnostics: combined IgG responses compared to serotype specific IgG responses.

Willemijn J M Janssen1, Andries C Bloem, Perijne Vellekoop, Gertjan J Driessen, Marianne Boes, Joris M van Montfrans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23881353     DOI： 10.1007/s10875-013-9925-y

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  12 in total

1.  Active vaccination in patients with common variable immunodeficiency (CVID).

Authors:  S Goldacker; R Draeger; K Warnatz; D Huzly; U Salzer; J Thiel; H Eibel; M Schlesier; H H Peter
Journal:  Clin Immunol       Date:  2007-06-29       Impact factor: 3.969

2.  Measurement of antibodies to pneumococcal polysaccharides with Luminex xMAP microsphere-based liquid arrays.

Authors:  Jerry W Pickering; Harry R Hill
Journal:  Methods Mol Biol       Date:  2012

3.  Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.

Authors:  Uwe Schauer; Frank Stemberg; Christian H L Rieger; Wolfgang Büttner; Michael Borte; Simone Schubert; Helga Möllers; Frank Riedel; Udo Herz; Harald Renz; Wilhelm Herzog
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

4.  Serotype-specific anti-pneumococcal IgG and immune competence: critical differences in interpretation criteria when different methods are used.

Authors:  Anne Balloch; Paul V Licciardi; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2012-09-30       Impact factor: 8.317

5.  Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.

Authors:  M A Breukels; G T Rijkers; M M Voorhorst-Ogink; B J Zegers; L A Sanders
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

Review 6.  Epidemiological differences among pneumococcal serotypes.

Authors:  William P Hausdorff; Daniel R Feikin; Keith P Klugman
Journal:  Lancet Infect Dis       Date:  2005-02       Impact factor: 25.071

7.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

8.  Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccine.

Authors:  Karin E M Elberse; Irina Tcherniaeva; Guy A M Berbers; Leo M Schouls
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

Review 9.  Common variable immunodeficiency: an update.

Authors:  Ulrich Salzer; Klaus Warnatz; Hans Hartmut Peter
Journal:  Arthritis Res Ther       Date:  2012-09-24       Impact factor: 5.156

10.  Salivary immune responses to the 7-valent pneumococcal conjugate vaccine in the first 2 years of life.

Authors:  Gerwin D Rodenburg; Elisabeth A M Sanders; Elske J M van Gils; Reinier H Veenhoven; Tomasz Zborowski; Germie P J M van den Dobbelsteen; Andries C Bloem; Guy A M Berbers; Debby Bogaert
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240
View more
  8 in total

Review 1.  Measuring immune responses to pneumococcal vaccines.

Authors:  David C LaFon; Moon H Nahm
Journal:  J Immunol Methods       Date:  2018-08-08       Impact factor: 2.303

2.  The Challenge of Immunoglobulin-G Subclass Deficiency and Specific Polysaccharide Antibody Deficiency--a Dutch Pediatric Cohort Study.

Authors:  Ellen J H Schatorjé; Everieke de Jong; Roeland W N M van Hout; Yumely García Vivas; Esther de Vries
Journal:  J Clin Immunol       Date:  2016-02-04       Impact factor: 8.317

3.  Value of the Overall Pneumococcal Polysaccharide Response in the Diagnosis of Primary Humoral Immunodeficiencies.

Authors:  Benjamin Lopez; Mathilde Bahuaud; Claire Fieschi; Souad Mehlal; Mohamed Jeljeli; Stéphanie Rogeau; Séverine Brabant; Anne-Sophie Deleplancque; Sylvain Dubucquoi; Sandrine Poizot; Louis Terriou; David Launay; Frédéric Batteux; Myriam Labalette; Guillaume Lefèvre
Journal:  Front Immunol       Date:  2017-12-20       Impact factor: 7.561

4.  Measurement of Typhim Vi IgG as a Diagnostic Tool to Determine Anti-polysaccharide Antibody Production Deficiency in Children.

Authors:  Kissy Guevara-Hoyer; Celia Gil; Antony R Parker; Leigh J Williams; Carmen Orte; Antonia Rodriguez de la Peña; Juliana Ochoa-Grullón; Edgard Rodriguez De Frias; Irene Serrano García; Sonia García-Gómez; M José Recio; Miguel Fernández-Arquero; Rebeca Pérez de Diego; Jose Tomas Ramos; Silvia Sánchez-Ramón
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

5.  Typhim vi immunization assists to discriminate primary antibody responses in hematological malignancies.

Authors:  J Ochoa-Grullón; C Orte; A Rodríguez de la Peña; K Guevara-Hoyer; G Cordero Torres; M Fernández-Arquero; I Serrano-García; M J Recio; R Pérez de Diego; S Sánchez-Ramón
Journal:  MethodsX       Date:  2020-05-29

6.  Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy.

Authors:  Ori Hassin; Yahya Abu Freih; Ran Hazan; Atar Lev; Keren S Zrihen; Raz Somech; Arnon Broides; Amit Nahum
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

7.  Variable immunodeficiency score upfront analytical link (VISUAL), a proposal for combined prognostic score at diagnosis of common variable immunodeficiency.

Authors:  Kissy Guevara-Hoyer; Adolfo Jiménez-Huete; Julia Vasconcelos; Esmeralda Neves; Silvia Sánchez-Ramón
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

8.  Focusing on Good Responders to Pneumococcal Polysaccharide Vaccination in General Hospital Patients Suspected for Immunodeficiency. A Decision Tree Based on the 23-Valent Pneumococcal IgG Assay.

Authors:  Lisanne M A Janssen; Michiel Heron; Jean-Luc Murk; Alexander C A P Leenders; Ger T Rijkers; Esther de Vries
Journal:  Front Immunol       Date:  2019-11-05       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.